SHAREHOLDER ALERT: WeissLaw LLP Investigates Amyris, Inc.

NEW YORK, July 28, 2020 /PRNewswire/ --

WeissLaw LLP (PRNewsfoto/WeissLaw LLP)


WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Amyris, Inc. ("AMRS" or the "Company") (NASDAQ: AMRS) in connection with the Company's June 1 and June 4, 2020 financing transactions requiring the issuance of AMRS common stock.  The financing transactions will ultimately yield approximately $200 million.  Among other things, the financing transactions permit the Company's largest stockholder, Foris Ventures, LLC ("Foris"), an entity controlled by AMRS board member John Doerr, to obtain AMRS common stock at $3.00 per share, which represents a 34% discount to AMRS's July 27, 2020 closing price of $4.54.  

If you own AMRS shares and wish to discuss this investigation or have any questions concerning this notice or your rights or interests, visit our website:

Or please contact:
Joshua Rubin, Esq.
WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY  10036
(212) 682-3025
(888) 593-4771

WeissLaw is investigating whether AMRS's board was acting in the best interest of AMRS's common stockholders by agreeing to the financing transactions and common stock issuance, which seem to primarily benefit Foris and Mr. Doerr.  Of particular concern is the ability of Foris to obtain Company common stock at a significant discount, as well as the lack of full disclosure regarding the financing transactions and common stock issuance included in AMRS's July 6, 2020 definitive proxy statement. 

WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties.  We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases.  If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at


Cision View original content to download multimedia:


Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.